FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022175692> ?p ?o ?g. }

• W2022175692 endingPage "54" @default.
• W2022175692 startingPage "49" @default.
• W2022175692 abstract "Oncolytic immunotherapies (OI) selectively infect, amplify within and destroy cancer cells, thereby representing a novel class of anti-cancer therapy. In addition to this primary mechanism-of-action (MOA), OI based on vaccinia have been shown to selectively target tumor-associated vasculature, triggering an acute reduction in tumor perfusion. This review focuses on a third complementary MOA for this product class: the induction of active immunotherapy. While the active immunotherapy approach has been validated by recent product approvals, the field is still faced with significant challenges. Tumors have evolved diverse mechanisms to hide from immune-mediated destruction. Here we hypothesize that oncolytic immunotherapy replication within tumors may tip the immune balance to allow for the effective induction and execution of adaptive anti-tumor immunity, resulting in long-term tumor control following OI clearance. This immune activation against the cancer can be augmented through OI ‘arming’ for the expression of immunostimulatory transgene products from the virus genome. With the first vaccinia OI (Pexa-Vec, thymidine kinase-inactivated vaccinia expressing Granulocyte-colony stimulating factor [GM-CSF]) now in advanced-stage clinical trials, it has become more important than ever to understand the complimentary MOA that contributes to tumor destruction and control in patients." @default.
• W2022175692 created "2016-06-24" @default.
• W2022175692 creator A5033267651 @default.
• W2022175692 creator A5043573924 @default.
• W2022175692 creator A5044195657 @default.
• W2022175692 creator A5054250864 @default.
• W2022175692 creator A5066566375 @default.
• W2022175692 creator A5088226144 @default.
• W2022175692 date "2015-08-01" @default.
• W2022175692 modified "2023-10-17" @default.
• W2022175692 title "Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic" @default.
• W2022175692 cites W1905216348 @default.
• W2022175692 cites W1965497380 @default.
• W2022175692 cites W1966046743 @default.
• W2022175692 cites W1978558644 @default.
• W2022175692 cites W1979631368 @default.
• W2022175692 cites W1983946589 @default.
• W2022175692 cites W1989295263 @default.
• W2022175692 cites W2000467533 @default.
• W2022175692 cites W2001436607 @default.
• W2022175692 cites W2002589386 @default.
• W2022175692 cites W2004630197 @default.
• W2022175692 cites W2009087361 @default.
• W2022175692 cites W2013219140 @default.
• W2022175692 cites W2020331580 @default.
• W2022175692 cites W2020849247 @default.
• W2022175692 cites W2029624351 @default.
• W2022175692 cites W2029677668 @default.
• W2022175692 cites W2051589513 @default.
• W2022175692 cites W2051782273 @default.
• W2022175692 cites W2058025467 @default.
• W2022175692 cites W2060006845 @default.
• W2022175692 cites W2066171305 @default.
• W2022175692 cites W2070624905 @default.
• W2022175692 cites W2071275789 @default.
• W2022175692 cites W2075631864 @default.
• W2022175692 cites W2076674654 @default.
• W2022175692 cites W2079647238 @default.
• W2022175692 cites W2090732350 @default.
• W2022175692 cites W2093059993 @default.
• W2022175692 cites W2095406487 @default.
• W2022175692 cites W2098245192 @default.
• W2022175692 cites W2101058247 @default.
• W2022175692 cites W2108595427 @default.
• W2022175692 cites W2113321923 @default.
• W2022175692 cites W2118012938 @default.
• W2022175692 cites W2130423245 @default.
• W2022175692 cites W2132361489 @default.
• W2022175692 cites W2144350507 @default.
• W2022175692 cites W2151943479 @default.
• W2022175692 cites W2155544754 @default.
• W2022175692 cites W2157215695 @default.
• W2022175692 cites W2161520972 @default.
• W2022175692 cites W2167451108 @default.
• W2022175692 cites W4238358844 @default.
• W2022175692 cites W4238827986 @default.
• W2022175692 cites W81873316 @default.
• W2022175692 doi "https://doi.org/10.1016/j.coviro.2015.03.016" @default.
• W2022175692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25900822" @default.
• W2022175692 hasPublicationYear "2015" @default.
• W2022175692 type Work @default.
• W2022175692 sameAs 2022175692 @default.
• W2022175692 citedByCount "38" @default.
• W2022175692 countsByYear W20221756922015 @default.
• W2022175692 countsByYear W20221756922016 @default.
• W2022175692 countsByYear W20221756922017 @default.
• W2022175692 countsByYear W20221756922018 @default.
• W2022175692 countsByYear W20221756922019 @default.
• W2022175692 countsByYear W20221756922020 @default.
• W2022175692 countsByYear W20221756922021 @default.
• W2022175692 countsByYear W20221756922022 @default.
• W2022175692 countsByYear W20221756922023 @default.
• W2022175692 crossrefType "journal-article" @default.
• W2022175692 hasAuthorship W2022175692A5033267651 @default.
• W2022175692 hasAuthorship W2022175692A5043573924 @default.
• W2022175692 hasAuthorship W2022175692A5044195657 @default.
• W2022175692 hasAuthorship W2022175692A5054250864 @default.
• W2022175692 hasAuthorship W2022175692A5066566375 @default.
• W2022175692 hasAuthorship W2022175692A5088226144 @default.
• W2022175692 hasConcept C104317684 @default.
• W2022175692 hasConcept C121608353 @default.
• W2022175692 hasConcept C203014093 @default.
• W2022175692 hasConcept C2522874641 @default.
• W2022175692 hasConcept C2777701055 @default.
• W2022175692 hasConcept C2780674031 @default.
• W2022175692 hasConcept C2781356689 @default.
• W2022175692 hasConcept C40767141 @default.
• W2022175692 hasConcept C49744831 @default.
• W2022175692 hasConcept C502942594 @default.
• W2022175692 hasConcept C54355233 @default.
• W2022175692 hasConcept C55493867 @default.
• W2022175692 hasConcept C82210918 @default.
• W2022175692 hasConcept C86803240 @default.
• W2022175692 hasConcept C8891405 @default.
• W2022175692 hasConceptScore W2022175692C104317684 @default.
• W2022175692 hasConceptScore W2022175692C121608353 @default.
• W2022175692 hasConceptScore W2022175692C203014093 @default.
• W2022175692 hasConceptScore W2022175692C2522874641 @default.

• next